Cerebrospinal fluid GABA levels in chronic migraine with and without depression

被引:30
|
作者
Vieira, D. S. S. [1 ]
Naffah-Mazacoratti, M. G. [1 ]
Zukerman, E. [1 ]
Soares, C. A. Senne [1 ]
Alonso, E. O. [1 ]
Faulhaber, M. H. W. [1 ]
Cavalheiro, E. A. [1 ]
Peres, M. F. P. [1 ]
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Inst Israel Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil
关键词
chronic migraine; depression; GABA; pathophysiology; cerebrospinal fluid;
D O I
10.1016/j.brainres.2006.03.051
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Psychiatric comorbidity is one of the key elements in chronic migraine (CM) management. Depression is particularly common in these patients, occurring in up to 85%. Preclinical studies have suggested that gamma-aminobutyric acid (GABA) levels may be decreased in animal models of depression. Also, clinical studies have reported low level in mood disorder patients for both plasma and cerebrospinal fluid (CSF) GABA. We hypothesized that low GABA levels in the brain might be related to the depression associated with CM. We studied 14 chronic migraine patients, with or without depression, compared to age-and sex-matched controls. CSF GABA levels were measured by HPLC. CSF GABA levels showed significant lower levels in depressed patients than those without depression. No difference was found when comparing patients versus controls. A GABA deficiency may be the underlying mechanism of depression in CM. Hence, preventive therapies modulating GABA neurotransmission could be used in CM associated with depression. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 50 条
  • [1] Cerebrospinal fluid glutamate levels in chronic migraine
    Peres, MFP
    Zukerman, E
    Soares, CAS
    Alonso, EO
    Santos, BFC
    Faulhaber, MHW
    CEPHALALGIA, 2004, 24 (09) : 735 - 739
  • [2] Endocannabinoid levels in chronic migraine: cerebrospinal fluid findings suggest a failure of this system
    Sarchielli, P
    Pini, LA
    Rossi, C
    Baldi, A
    Floridi, A
    Calabresi, P
    CEPHALALGIA, 2005, 25 (10) : 884 - 884
  • [3] Nociceptin and PGE2 levels in cerebrospinal fluid of chronic migraine and fibromyalgic patients
    Sarchielli, P
    Rossi, C
    Coppola, F
    Floridi, A
    Floridi, A
    Calabresi, P
    CEPHALALGIA, 2005, 25 (10) : 884 - 884
  • [4] TAURINE LEVELS IN PLASMA AND CEREBROSPINAL-FLUID IN MIGRAINE PATIENTS
    MARTINEZ, F
    CASTILLO, J
    LEIRA, R
    PRIETO, JM
    LEMA, M
    NOYA, M
    HEADACHE, 1993, 33 (06): : 324 - 327
  • [5] Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia
    Sarchielli, P
    Alberti, A
    Candeliere, A
    Floridi, A
    Capocchi, G
    Calabresi, P
    CEPHALALGIA, 2006, 26 (04) : 409 - 415
  • [6] Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression
    Rong Fu
    Hyder Jinnah
    J. Lucas Mckay
    Andrew H. Miller
    Jennifer C. Felger
    Eugene W. Farber
    Sanjay Sharma
    Neil Whicker
    Raeanne C. Moore
    Donald Franklin
    Scott L. Letendre
    Albert M. Anderson
    Journal of NeuroVirology, 2023, 29 : 440 - 448
  • [7] Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression
    Fu, Rong
    Jinnah, Hyder
    Mckay, J. Lucas
    Miller, Andrew H.
    Felger, Jennifer C.
    Farber, Eugene W.
    Sharma, Sanjay
    Whicker, Neil
    Moore, Raeanne C.
    Franklin, Donald
    Letendre, Scott L.
    Anderson, Albert M.
    JOURNAL OF NEUROVIROLOGY, 2023, 29 (04) : 440 - 448
  • [8] Aggressivity, suicide attempts, and depression: Relationship to cerebrospinal fluid monoamine metabolite levels
    Placidi, GPA
    Oquendo, MA
    Malone, KM
    Huang, YY
    Ellis, SP
    Mann, JJ
    BIOLOGICAL PSYCHIATRY, 2001, 50 (10) : 783 - 791
  • [9] Cerebrospinal fluid sodium increases in migraine
    Harrington, Michael G.
    Fonteh, Alfred N.
    Cowan, Robert P.
    Perrine, Kathy
    Pogoda, Janice M.
    Biringer, Roger G.
    Huhmer, Andreas F. R.
    HEADACHE, 2006, 46 (07): : 1128 - 1135
  • [10] CLINICAL RELEVANCE OF MEASURING GABA CONCENTRATIONS IN CEREBROSPINAL-FLUID
    SCHECHTER, PJ
    SJOERDSMA, A
    NEUROCHEMICAL RESEARCH, 1990, 15 (04) : 419 - 423